Distributions of genetic diversity exhibit similar statistical forms across phylogenetically distant species in the human gut. by William R. Shoemaker (16632093)

“…In <b>c</b>, statistical fits of a gamma (the distribution predicted by the SLM) and a lognormal (a point of comparison) are illustrated as black lines. …”

Chronic <i>in vivo</i> imaging in adult mice reveals improvements in ipsilateral retinotopic maps after monocular enucleation (ME) of the contralateral eye. by Spencer L. Smith (366143)

“…(C, lower panel) Change in scatter is plotted versus the change in area of responsive cortex showing that scatter values consistently decrease (points lie below the horizontal line) while no trend in area changes is observed (points evenly distributed on either side of the vertical line). …”

Characterization of the interactions between chitosan/whey protein at different conditions by Lizhu YE (5110604)

“…The combination of chitosan and whey proteins was electrostatic attracting at pH 5.5 and 6.0. At low chitosan addition, the complexes formed at pH 5.5 showed higher viscosity and the complexes formed at pH 6.0 showed a shear-thinning behaviour. …”

Characterization of the interactions between chitosan/whey protein at different conditions by Lizhu YE (5110604)

“…The combination of chitosan and whey proteins was electrostatic attracting at pH 5.5 and 6.0. At low chitosan addition, the complexes formed at pH 5.5 showed higher viscosity and the complexes formed at pH 6.0 showed a shear-thinning behaviour. …”

Transmission.mp4 by Alain Abou Khalil (6680339)

“…In this video we observe the double-wing featured shown in figure 5 of the manuscript. The transmission of the waveguide increases for a liquid's RI of 1.602 matching the glass's. while on the other side, with a liquid of 1.604 matching the effective RI of the guided mode we observe a decrease in the transmission.…”

WNT enhances acinar progenitor activity through LRP6 signaling. by Lisa M. Arendt (204431)

“…(<b>I, J</b>) WNT1 expression increased acinar colonies, while reduced LRP6 expression diminished acinar colonies, when WNT1, EV, shscram, and shLRP6 expressing MECs were grown as mammospheres (<b>I</b>) or floating colonies (<b>J</b>) prior to plating on collagen (n = 5 patient samples; mean±s.e.m.). (<b>K</b>) TBX3 MCF10A cells demonstrated significantly increased expression of <i>WNT2B</i> and <i>WNT9A</i> compared with EV cells. …”

Fluticasone propionate reduces GATA-3 association with importin-α and GATA-3 nuclear import. by Kittipong Maneechotesuwan (372725)

“…(C) Western blot analysis of HuT-78 cells treated with FP and anti-CD3/CD28 co-stimulation demonstrated a concentration-dependent decrease in GATA-3–importin-α association at 20 min. …”

Data Sheet 3_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 1_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 8_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 2_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 10_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 12_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 6_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Functional characterization of sEpoR. by Eliyahu V. Khankin (367092)

“…Ratios of phospho/total Stat-5 (mean ± SD, n = 3) represented as a percentage of control (Epo alone). …”

Excitability of motor cortex is not affected by cTBS over somatosensory (“som”) cortex, whereas cTBS over motor cortex suppresses its excitability. by Neeraj Kumar (109718)

“…<p>cTBS to somatosensory cortex decreases perceptual acuity. (A) Mean time series of MEPs recorded from biceps brachii pre- (blue) and post-cTBS (red) from a representative participant. …”